Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease.
about
Assessing the end-organ in peripheral arterial occlusive disease-from contrast-enhanced ultrasound to blood-oxygen-level-dependent MR imagingExercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefitsA multiscale computational model predicts distribution of anti-angiogenic isoform VEGF165b in peripheral arterial disease in human and mouseArterial spin labeling perfusion cardiovascular magnetic resonance of the calf in peripheral arterial disease: cuff occlusion hyperemia vs exercise.Optical probing of gastrocnemius in patients with peripheral artery disease characterizes myopathic biochemical alterations and correlates with stage of disease.Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patientsRelationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease.VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.Therapeutic angiogenesis for critical limb ischaemia.Resting energy expenditure in patients with intermittent claudication and critical limb ischemia.Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.Clinical predictors of ventilatory threshold achievement in patients with claudication.The feasibility of measuring phosphocreatine recovery kinetics in muscle using a single-shot (31)P RARE MRI sequence.A near infrared spectroscopy-based test of calf muscle function in patients with peripheral arterial disease.Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial diseaseRelationship of physical function to vastus lateralis capillary density and metabolic enzyme activity in elderly men and women.Exercise training and peripheral arterial disease.Endothelial FoxO1 is an intrinsic regulator of thrombospondin 1 expression that restrains angiogenesis in ischemic muscle.Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease.A single bout of resistance exercise does not modify cardiovascular responses during daily activities in patients with peripheral artery disease.Stem cells of the lower limb: their role and potential in management of critical limb ischemia.Regulation of skeletal muscle capillary growth in exercise and disease.Stem Cell Smart Technology, where are we now and how far we have to go?Combined Lower Limb Revascularisation and Supervised Exercise Training for Patients with Peripheral Arterial Disease: A Systematic Review of Randomised Controlled Trials.Factors Associated with Sedentary Behavior in Patients with Intermittent Claudication.Systems Pharmacology of VEGF165b in Peripheral Artery Disease.Dietary Nitrate supplementation in Cardiovascular Health: An ergogenic aid or exercise therapeutic?Sarcopenia in Peripheral Arterial Disease: Prevalence and Effect on Functional Status.Circulating Angiogenic Growth Factors in Diabetes Patients with Peripheral Arterial Disease and Exertional Leg Pain in Ghana.Reliability of the vascular claudication reporting in diabetic patients with peripheral arterial disease: a study with near-infrared spectroscopy.Capillary ultrastructure and mitochondrial volume density in skeletal muscle in relation to reduced exercise capacity of patients with intermittent claudication.Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in ratStages of health behavior change and factors associated with physical activity in patients with intermittent claudicationRelação entre aptidão física e os indicadores de qualidade de vida de indivíduos com claudicação intermitenteExercícios resistidos terapêuticos para indivíduos com doença arterial obstrutiva periférica: evidências para a prescrição
P2860
Q27024253-5A487FC2-33E2-49A3-A01B-137ACBAB51B5Q27694706-6940BDD5-E6CC-4F05-8F0C-7A91454D6307Q30275400-A9C5E027-9925-4AA0-B0A0-DBAD23E76B19Q30300171-3EBE9F2B-3216-48F9-AADD-90DAF86D0D55Q30360841-DD6556C9-A757-4263-B8EF-38FC4C0900FAQ30422358-39F59CB4-A094-4B9F-8CEA-3452906AC068Q30426220-04119F91-A24C-423A-9C52-BFBFD94545CBQ30432040-0ABE7DC0-5A67-4446-93FA-F7A57C76EE24Q30456666-6CB3C76E-336D-4C7E-A558-37FD052BC8F0Q33869269-42A6415E-B2EB-4C41-9E71-09B8B42FE607Q33885504-F61F9537-6BCC-4622-87CA-0C98AD288467Q34861539-6F5CF7FB-DD6B-4898-812F-062F6975AAC3Q35046380-F1F2018E-0F4F-42F8-B5FE-4B7D8B5EAB7AQ35141541-E33B3465-7F2C-4EC7-AB7D-F8DEF9C68CF7Q36676706-6412D01B-0052-4119-B67F-AB1D17B47A37Q36880215-67E341AB-9353-4E61-8ABD-76DF6674F1FBQ37157213-643B4E1D-0EDD-4FD0-8B13-AFCCED9DF62FQ37292426-6E131AB5-60C7-46B6-8E49-56AD4E2578F2Q37441971-6A3D469A-B9A3-49AA-BCB8-5E3B0EE1308FQ37700051-AE4593E7-099A-410A-B003-D1DBABF98909Q38133471-2B9BBE89-63A3-4F44-8F5C-EB8531D34BA8Q38629583-A62E1B6C-6E2A-49F0-B08C-736CF05203A0Q38637333-847BA7EA-DDBB-44FB-A82F-4D83A5537E11Q38978543-4964AAC5-23B2-4F10-A480-E7E373060ED1Q39260437-F09556B2-BE0E-4E8A-B054-96FF621F7184Q45074473-97C247FD-ADFF-453D-97C4-9DF13D382466Q46269203-45423C4F-5927-4DD4-B012-A5DD3F6240DCQ47708476-B97FA689-8F5F-4DFE-BDD5-FCCD9BA4BFF2Q49417865-9944A5C3-1860-4557-8265-33CF117E76F9Q50803425-45F52721-1776-4F8F-8635-B9FAE8D90722Q52854593-75842BEE-694E-4151-9CC4-83E5F7D2623CQ56450866-33DE6D64-4CB5-4601-B040-8DEE9D4BE413Q57556958-F55F90DE-5CDA-4EC1-809A-033990F84137Q57556974-9BF0BC8F-36D7-407A-8D14-B01DD66DA3F3Q57557064-990E39C6-17D2-41D1-84E3-EDD7865D80DB
P2860
Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Skeletal muscle phenotype is a ...... h peripheral arterial disease.
@en
Skeletal muscle phenotype is a ...... h peripheral arterial disease.
@nl
type
label
Skeletal muscle phenotype is a ...... h peripheral arterial disease.
@en
Skeletal muscle phenotype is a ...... h peripheral arterial disease.
@nl
prefLabel
Skeletal muscle phenotype is a ...... h peripheral arterial disease.
@en
Skeletal muscle phenotype is a ...... h peripheral arterial disease.
@nl
P2093
P50
P1476
Skeletal muscle phenotype is a ...... h peripheral arterial disease.
@en
P2093
Anita A Green
Mark A Febbraio
Philip J Walker
Simon Green
P304
P356
10.1016/J.JVS.2005.01.037
P577
2005-05-01T00:00:00Z